Evidence map›Paper›PMID 22893614›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2013

Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.

Kyung-Hyun Park-Min, Eun Young Lee, Neal K Moskowitz, Elisha Lim, Sun-Kyeong Lee, Joseph A Lorenzo, Chuanxin Huang, Ari M Melnick, P Edward Purdue, Steven R Goldring and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Biological Effects of β-Glucans on Osteoclastogenesis.Molecules (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Article
  17. Monocyte Subsets With High Osteoclastogenic Potential and Their Epigenetic Regulation Orchestrated by IRF8.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  18. Article
  19. β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Kyung-Hyun Park-MinArthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, USA.
Eun Young Lee
Neal K Moskowitz
Elisha Lim
Sun-Kyeong Lee
Joseph A Lorenzo
Chuanxin Huang
Ari M Melnick
P Edward Purdue
Steven R Goldring
Lionel B Ivashkiv
Hospital for Special Surgery · USCornell University · USUConn Health · USSeoul National University · KR

Funding

STEROID THERAPY AND CYTOKINES IN RHEUMATIC DISEASESR01AI046712 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 2000 to 2025
$12.5M
CYTOKINE REGULATION OF RA SYNOVIOCYTE PHENOTYPER01AR046713 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 1999 to 2025
$8.3M
Negative Regulation of OsteoclastogenesisR01DE019420 · NIDCR · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 2008 to 2022
$6.0M
Negative Regulation of Osteoclastogenesis by Inflammatory SignalsK99AR061430 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI PARK-MIN, KYUNG-HYUN · 2012 to 2013
$179k
NIAID NIH HHS R01 AI046712NIAMS NIH HHS K99 AR061430NIAMS NIH HHS R01 AR046713NIDCR NIH HHS R01 DE019420
6 · The paper itself

Abstract

Negative regulation of osteoclastogenesis is important for bone homeostasis and prevention of excessive bone resorption in inflammatory and other diseases. Mechanisms that directly suppress osteoclastogenesis are not well understood. In this study we investigated regulation of osteoclast differentiation by the β2 integrin CD11b/CD18 that is expressed on myeloid lineage osteoclast precursors. CD11b-deficient mice exhibited decreased bone mass that was associated with increased osteoclast numbers and decreased bone formation. Accordingly, CD11b and β2 integrin signaling suppressed osteoclast differentiation by preventing receptor activator of NF-κB ligand (RANKL)-induced induction of the master regulator of osteoclastogenesis nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) and of downstream osteoclast-related NFATc1 target genes. CD11b suppressed induction of NFATc1 by the complementary mechanisms of downregulation of RANK expression and induction of recruitment of the transcriptional repressor B-cell lymphoma 6 (BCL6) to the NFATC1 gene. These findings identify CD11b as a negative regulator of the earliest stages of osteoclast differentiation, and provide an inducible mechanism by which environmental cues suppress osteoclastogenesis by activating a transcriptional repressor that makes genes refractory to osteoclastogenic signaling.

Indexed as

Cell DifferentiationSignal TransductionAnimalsCD11b AntigenCD18 AntigensCell CountDNA-Binding ProteinsFemurFibrinogenHumansIntegrin beta3MiceMice, Inbred C57BLNFATC Transcription FactorsOrgan SizeOsteoclastsBCL6 protein, humanCD11b AntigenCD18 AntigensDNA-Binding ProteinsFibrinogenIntegrin beta3NFATC Transcription FactorsProto-Oncogene Proteins c-bcl-6RANK Ligand

Identifiers

PMID22893614
PMCPMC3522783
OpenAlexW2014334953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.